Ioversol
Description References- Product Name
- Ioversol
- CAS No.
- 87771-40-2
- Chemical Name
- Ioversol
- Synonyms
- Optiray;Loversol;P 530;mp-328;oversol;IOVERSOL;Iodophorol;Optiray 320;Ioversol API;Ioversol (200 mg)
- CBNumber
- CB7374919
- Molecular Formula
- C18H24I3N3O9
- Formula Weight
- 807.11
- MOL File
- 87771-40-2.mol
Ioversol Property
- Melting point:
- 180-182°C
- Boiling point:
- 864.9±65.0 °C(Predicted)
- Density
- d37 1.371 (c = 320 mgI/ml)
- storage temp.
- Refrigerator
- solubility
- DMSO (Sparingly), Methanol (Slightly)
- pka
- 11.34±0.46(Predicted)
- form
- Solid
- color
- White to Off-White
- CAS DataBase Reference
- 87771-40-2(CAS DataBase Reference)
Safety
- HS Code
- 2924296000
- Toxicity
- LD50 in mice, rats, rabbits, dogs (gI/kg): 17, 15, >25, >12 i.v.; in male, female rats (mgI/kg): 1000, >1200 intracisternally (Ralston)
N-Bromosuccinimide Price
- Product number
- I737000
- Product name
- Ioversol
- Packaging
- 1g
- Price
- $225
- Updated
- 2021/12/16
- Product number
- API0003020
- Product name
- IOVERSOL
- Purity
- 95.00%
- Packaging
- 25MG
- Price
- $425.75
- Updated
- 2021/12/16
- Product number
- API0003020
- Product name
- IOVERSOL
- Purity
- 95.00%
- Packaging
- 100MG
- Price
- $904.55
- Updated
- 2021/12/16
- Product number
- G363
- Product name
- Ioversol
- Packaging
- 5mg
- Price
- $32
- Updated
- 2021/12/16
- Product number
- API0003020
- Product name
- IOVERSOL
- Purity
- 95.00%
- Packaging
- 1G
- Price
- $1593.9
- Updated
- 2021/12/16
Ioversol Chemical Properties,Usage,Production
Description
Loversol is a kind of organioiodine compound that used as a contrast medium. It has high iodine content as well as several hydrophilic groups. It can be used for peripheral and coronary arteriography and left ventriculograpy, cardiovascular system angiography, cerebral angiography, venography, tomographic imaging of the head and body as well as intravenous excretory urography. It takes effects through opacifying those vessels in the path of the flow of the contrast medium, permitting radiographic visualization of the internal structure.
References
http://www.rxlist.com/optiray-injection-drug.htm
https://www.drugbank.ca/drugs/DB09134
Chemical Properties
White Solid
Uses
Loversol is a radiopaque contrast agent. Ioversol contains iodine, a substance that absorbs x-rays. Contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination.
Uses
Nonionic, low osmolality, radiographic contrast agent. Diagnostic aid (radiopaque medium).
Definition
Loversol is classified as an organoiodine compound and is used as a contrast dye in diagnostic procedures. It contains high levels of iodine in addition to various hydrophilic groups.
brand name
Optiray (Mallinckrodt).
General Description
Ioversol is a low-osmolar, nonionicmonomer with 47% bound iodine content. It is indicated forangiography, excretory urography, ventriculography, andvarious CT procedures.
Side effects
The most common reaction is nausea, occurring at a rate of 1 percent.
Serious adverse reactions have been reported during post-approval use of Optiray. These serious adverse reactions include but are not limited to: anaphylactic reactions, arrhythmias, temporary blindness, tongue edema, seizures, respiratory arrest, bronchospasm, laryngeal spasm and thrombosis.
Ioversol Preparation Products And Raw materials
Raw materials
Preparation Products
Ioversol Suppliers
- Tel
- --
- Fax
- --
- sales@chemos-group.com
- Country
- Germany
- ProdList
- 6350
- Advantage
- 71
View Lastest Price from Ioversol manufacturers
- Product
- Ioversol 87771-40-2
- Price
- US $0.00/KG
- Min. Order
- 1KG
- Purity
- 99.2~101.0%
- Supply Ability
- 5000KG/month
- Release date
- 2021-07-03
- Product
- Ioversol. 87771-40-2
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- More Than 99%
- Supply Ability
- 100kg/Month
- Release date
- 2024-12-12
- Product
- Ioversol 87771-40-2
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- More Than 99%
- Supply Ability
- 100kg/Month
- Release date
- 2024-09-19